Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (8953)	6/4/1998 6:02:00 PM
From: blankmind	Respond to of 23519

- I agree. - Listen, the truth is going to eventually surface. If Vivus can maintain a presence in the ED market, the shorts will have to cover. Period. - If Vivus can't - then we lose. - I'm betting that MUSE has a following. Viagra - by all accounts - is a great drug. But it will only work for 70% of the people. I agree with the Cruttenden report. Hence, I think the shorts are going to get toasted on this move - as usually happens to them. - Meantime - get use to all the B.S. & obscure slams on Vivus. Press releases with 110 "severely sick & old" people; 2 pound weights hanging off penises; and everything else.